Delivery Order SPE2DB25D3022-SPE2DB25FWCAD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors valued at $1,218.01, with completion scheduled for August 22, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction within the broader federal medical supply chain. The contract specifies performance at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $7,798.34 with a completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's broader pharmaceutical supply contract portfolio. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $2,556.56 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The product will be performed and delivered from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors, with a contract ceiling value of $5,466.66 and an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical medical supplies to support federal healthcare needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $3,156.24. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing federal contract portfolio...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $2,702.70, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,819.28 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors with a completion date of July 24, 2025. This is a firm fixed price contract with no set-aside designation, awarded through open competition. The pharmaceutical distributor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCADDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors, valued at $2,964.51. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under an existing contract vehicle, utilizing the company's established capability to supply pharmaceutical products to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for military and veteran healthcare systems, supplying a wide range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The parent indefinite delivery contract enables the company to fulfill pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/23/25 |